Operating Income (Loss) in USD of Apyx Medical Corp from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Apyx Medical Corp quarterly/annual Operating Income (Loss) history and change rate from Q2 2010 to Q3 2025.
  • Apyx Medical Corp Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$832K, a 77.1% increase year-over-year.
  • Apyx Medical Corp Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$9.51M, a 55.9% increase year-over-year.
  • Apyx Medical Corp annual Operating Income (Loss) for 2024 was -$18.8M, a 9.19% decline from 2023.
  • Apyx Medical Corp annual Operating Income (Loss) for 2023 was -$17.3M, a 26.8% increase from 2022.
  • Apyx Medical Corp annual Operating Income (Loss) for 2022 was -$23.6M, a 63.1% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

Apyx Medical Corp Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$9.51M -$832K +$2.8M +77.1% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025
Q2 2025 -$12.3M -$2.57M +$2.97M +53.6% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 -$15.3M -$3.05M +$3.56M +53.9% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025
Q4 2024 -$18.8M -$3.05M +$2.73M +47.2% 01 Oct 2024 31 Dec 2024 10-K 13 Mar 2025
Q3 2024 -$21.6M -$3.64M +$1M +21.6% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025
Q2 2024 -$22.6M -$5.55M -$4.31M -349% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025
Q1 2024 -$18.3M -$6.62M -$1M -17.9% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025
Q4 2023 -$17.3M -$5.78M +$157K +2.65% 01 Oct 2023 31 Dec 2023 10-K 13 Mar 2025
Q3 2023 -$17.4M -$4.64M +$1.15M +19.8% 01 Jul 2023 30 Sep 2023 10-Q 08 Nov 2024
Q2 2023 -$18.6M -$1.24M +$4.74M +79.3% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 -$23.3M -$5.61M +$260K +4.43% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024
Q4 2022 -$23.6M -$5.93M -$4.24M -251% 01 Oct 2022 31 Dec 2022 10-K 21 Mar 2024
Q3 2022 -$19.3M -$5.78M -$1.81M -45.7% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 -$17.5M -$5.98M -$1.93M -47.8% 01 Apr 2022 30 Jun 2022 10-Q 11 Aug 2023
Q1 2022 -$15.6M -$5.87M -$1.13M -23.7% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q4 2021 -$14.4M -$1.69M +$361K +17.6% 01 Oct 2021 31 Dec 2021 10-K 16 Mar 2023
Q3 2021 -$14.8M -$3.97M +$403K +9.22% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 -$15.2M -$4.04M +$2.12M +34.4% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022
Q1 2021 -$17.3M -$4.75M +$2.75M +36.7% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022
Q4 2020 -$20.1M -$2.05M +$3.91M +65.6% 01 Oct 2020 31 Dec 2020 10-K 17 Mar 2022
Q3 2020 -$24M -$4.37M +$385K +8.1% 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021
Q2 2020 -$24.4M -$6.17M -$1.75M -39.5% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021
Q1 2020 -$22.6M -$7.49M -$1.76M -30.8% 01 Jan 2020 31 Mar 2020 10-Q 12 May 2021
Q4 2019 -$20.9M -$5.96M -$126K -2.16% 01 Oct 2019 31 Dec 2019 10-K 31 Mar 2021
Q3 2019 -$20.7M -$4.76M -$1.97M -70.6% 01 Jul 2019 30 Sep 2019 10-Q 09 Nov 2020
Q2 2019 -$18.8M -$4.42M -$1.49M -50.8% 01 Apr 2019 30 Jun 2019 10-Q 10 Aug 2020
Q1 2019 -$17.3M -$5.73M -$3.01M -111% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020
Q4 2018 -$14.3M -$5.84M +$2.17M +27.1% 01 Oct 2018 31 Dec 2018 10-K 31 Mar 2020
Q3 2018 -$16.5M -$2.79M +$45K +1.59% 01 Jul 2018 30 Sep 2018 10-Q/A 08 May 2020
Q2 2018 -$16.5M -$2.93M -$1.63M -125% 01 Apr 2018 30 Jun 2018 10-Q 07 Aug 2019
Q1 2018 -$14.9M -$2.72M -$983K -56.6% 01 Jan 2018 31 Mar 2018 10-Q/A 08 May 2020
Q4 2017 -$13.9M -$8.01M +$635K +7.35% 01 Oct 2017 31 Dec 2017 10-K 31 Mar 2020
Q3 2017 -$14.5M -$2.83M -$2.59M -1056% 01 Jul 2017 30 Sep 2017 10-Q/A 08 May 2020
Q2 2017 -$11.9M -$1.31M -$796K -156% 01 Apr 2017 30 Jun 2017 10-Q 01 Aug 2018
Q1 2017 -$11.1M -$1.74M +$256K +12.8% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018
Q4 2016 -$11.4M -$8.64M -$7.29M -539% 01 Oct 2016 31 Dec 2016 10-K 14 Mar 2019
Q3 2016 -$4.1M -$245K +$1.57M +86.5% 01 Jul 2016 30 Sep 2016 10-Q 03 Nov 2017
Q2 2016 -$5.67M -$510K +$1.04M +67.1% 01 Apr 2016 30 Jun 2016 10-Q 03 Aug 2017
Q1 2016 -$6.71M -$1.99M +$279K +12.3% 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017
Q4 2015 -$6.99M -$1.35M +$441K +24.6% 01 Oct 2015 31 Dec 2015 10-K 13 Mar 2018
Q3 2015 -$7.43M -$1.81M +$554K +23.4% 01 Jul 2015 30 Sep 2015 10-Q 27 Oct 2016
Q2 2015 -$7.98M -$1.55M +$198K +11.3% 01 Apr 2015 30 Jun 2015 10-Q 02 Aug 2016
Q1 2015 -$8.18M -$2.27M -$2.33M -4017% 01 Jan 2015 31 Mar 2015 10-Q 11 May 2016
Q4 2014 -$5.85M -$1.79M -$918K -105% 01 Oct 2014 31 Dec 2014 10-K 10 Mar 2017
Q3 2014 -$4.93M -$2.37M -$1.89M -398% 01 Jul 2014 30 Sep 2014 10-Q 05 Nov 2015
Q2 2014 -$3.04M -$1.75M -$96K -5.82% 01 Apr 2014 30 Jun 2014 10-Q 07 Aug 2015
Q1 2014 -$2.94M $58K +$723K 01 Jan 2014 31 Mar 2014 10-Q 08 May 2015
Q4 2013 -$3.67M -$876K -$1M -784% 01 Oct 2013 31 Dec 2013 10-K 18 Mar 2016
Q3 2013 -$2.66M -$475K -$757K -268% 01 Jul 2013 30 Sep 2013 10-Q 10 Nov 2014
Q2 2013 -$1.91M -$1.65M -$1.89M -788% 01 Apr 2013 30 Jun 2013 10-Q 08 Aug 2014
Q1 2013 -$15K -$665K -$1.06M -268% 01 Jan 2013 31 Mar 2013 10-Q 15 May 2014
Q4 2012 $1.05M $128K +$1.53M 01 Oct 2012 31 Dec 2012 10-K 27 Feb 2015
Q3 2012 -$482K $282K +$34K +13.7% 01 Jul 2012 30 Sep 2012 10-Q 14 Nov 2013
Q2 2012 -$516K $240K -$309K -56.3% 01 Apr 2012 30 Jun 2012 10-Q/A 25 Sep 2013
Q1 2012 -$207K $396K -$189K -32.3% 01 Jan 2012 31 Mar 2012 10-Q 15 May 2013
Q4 2011 -$18K -$1.4M 01 Oct 2011 31 Dec 2011 10-K/A 08 May 2014
Q3 2011 $248K +$363K 01 Jul 2011 30 Sep 2011 10-Q 14 Nov 2012
Q2 2011 $549K +$1.34M 01 Apr 2011 30 Jun 2011 10-Q 14 Aug 2012
Q1 2011 $585K 01 Jan 2011 31 Mar 2011 10-Q 15 May 2012
Q3 2010 -$115K 01 Jul 2010 30 Sep 2010 10-Q 14 Nov 2011
Q2 2010 -$791K 01 Apr 2010 30 Jun 2010 10-Q 12 Aug 2011

Apyx Medical Corp Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$18.8M -$1.59M -9.19% 01 Jan 2024 31 Dec 2024 10-K 13 Mar 2025
2023 -$17.3M +$6.3M +26.8% 01 Jan 2023 31 Dec 2023 10-K 13 Mar 2025
2022 -$23.6M -$9.11M -63.1% 01 Jan 2022 31 Dec 2022 10-K 21 Mar 2024
2021 -$14.4M +$5.64M +28.1% 01 Jan 2021 31 Dec 2021 10-K 16 Mar 2023
2020 -$20.1M +$786K +3.77% 01 Jan 2020 31 Dec 2020 10-K 17 Mar 2022
2019 -$20.9M -$6.59M -46.2% 01 Jan 2019 31 Dec 2019 10-K 31 Mar 2021
2018 -$14.3M -$391K -2.82% 01 Jan 2018 31 Dec 2018 10-K 31 Mar 2020
2017 -$13.9M -$2.49M -21.9% 01 Jan 2017 31 Dec 2017 10-K 31 Mar 2020
2016 -$11.4M -$4.41M -63.1% 01 Jan 2016 31 Dec 2016 10-K 14 Mar 2019
2015 -$6.99M -$1.14M -19.4% 01 Jan 2015 31 Dec 2015 10-K 13 Mar 2018
2014 -$5.85M -$2.18M -59.5% 01 Jan 2014 31 Dec 2014 10-K 10 Mar 2017
2013 -$3.67M -$4.71M -450% 01 Jan 2013 31 Dec 2013 10-K 18 Mar 2016
2012 $1.05M +$1.06M 01 Jan 2012 31 Dec 2012 10-K 27 Feb 2015
2011 -$18K +$2.73M +99.3% 01 Jan 2011 31 Dec 2011 10-K/A 08 May 2014
2010 -$2.75M 01 Jan 2010 31 Dec 2010 10-K 01 Apr 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.